To view the Enterprise Awards applications, please click on each award heading below.

Nomination Form »

The deadline for nominations was Friday, November 17th.

Healthcare Innovator

Sponsor: Independence Blue Cross

Criteria:

• The nominee can be a company, researcher, or investor providing an innovative solution that has the potential to make a large and positive impact on cost, quality, and/or access in health care.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

• The Nominee must demonstrate creativity and passion to re-thinking healthcare in the region and to driving exceptional health outcomes or dramatically lowing costs.
• The Nominee should have a demonstrated business model for its solution and demonstrate the ability to generate rapid growth or adoption.
• The nominee should be able to demonstrate return on investment or clinical impact of its solution.
• The nominee can be in any sector (technology, life sciences, investment, health care delivery, etc.), but must be serving the healthcare industry in Greater Philadelphia.

Life Sciences & Healthcare Startup

Sponsors:  Blank Rome

Criteria:

• Company must have been founded, launched meaningful operations, or pivoted to current strategic focus at some point in the period between January 1, 2020, and December 31, 2023.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

• Discuss product innovation including unmet market need and how that is uniquely addressed by your product/service.
• Discuss the management team and its record of achieving success.
• Provide demonstration of success (e.g., significant milestones, raising capital, revenue, etc.).
• Describe the R&D investment strategy.
• What did the company do to overcome challenges in financing, development, or commercialization?

Life Sciences & Healthcare CEO

Sponsors:  EY and Morgan Lewis

Criteria: Individual’s background and the company’s success to date.

• Company must be based in the region and their company must have their HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
• CEO must be in her/his position for at least 2 years.

Key Considerations:

• CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
• Leadership and impact in industry and/or market.
• Ability to attract and retain talented resources.
• Company milestones including financial accomplishments and a strategy for continued company success.
• Community/industry involvement.
• Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the life sciences/healthcare industry in the region.
• Ability to attract and retain talented resources.

Life Sciences & Healthcare Emerging

Sponsors: RSM

Criteria:

• Company must have been in operation beginning on January 1, 2020.  The Company should have no more than 8 years of operating results since its founding.
• Must have sales, grants, or licensing fees.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

• Describe product or service, including proprietary applications or other competitive advantage.
• The impact on the clinical problem this product or innovation is trying to solve (e.g. saving a hospital money on a procedure, making a clinician more productive, etc.).
• Company milestones including strategic decisions made by the management team that led to growth in revenues and/or earnings, corporate collaborations, or license deals (e.g. ability to raise capital, strategy to achieve break even, ability to realize high gross margins, etc.).

Life Sciences & Healthcare Investment Deal

Sponsor: TBA

Criteria:

• Deal must have been fully executed between November 1, 2022, and October 31, 2023.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees and consultants must be based in the region.
• Events that qualify for this category include: IPO, Capital Raise, Buy-side or Sell-side of a Merger & Acquisition Transaction.

Key Considerations:

• Realized returns for the investors and management.
• EBITDA margin and revenue growth.
• Strategic considerations of the deal (e.g. commercial strategy, innovation, and contribution to market development.
• Company performance prior to transaction.
• How the sale or purchase impacted the broader industry(s) of the buyer and/or seller.

Technology Startup

A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.

Sponsors:  Troutman Pepper

Criteria:

• Company should have been founded, launched meaningful operations, or pivoted to current strategic focus at some point in the period between January 1, 2020, and December 31, 2023.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

• Product or service innovation including market need or assessment.
• Potential for significant growth.
• The management team and its record of achieving success.
• A demonstration of success such as significant milestones, raising capital, and revenue.

Technology CEO

A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.

Sponsor: TBA

Criteria:

• Individual’s background and the company’s success to date.
• CEO must be based in the region and their company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
• CEO must be in her/his position for at least 2 years.

Key Considerations:

• CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
• Leadership and impact in industry and/or market.
• Ability to attract and retain talented resources.
• Company milestones including financial accomplishments and a strategy for continued company success.
• Community/industry involvement.
• Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the technology industry in the region.

Technology Investment Deal

Sponsor: JPMorgan

Criteria:

• Deal must have been fully executed between November 1, 2022, and October 31, 2023.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees and consultants must be based in the region.
• Events that qualify for this category include: IPO, Capital Raise, Buy-side or Sell-side of a Merger & Acquisition Transaction.

Key Considerations:

• Realized returns for the investors and management.
• EBITDA margin and revenue growth.
• Strategic considerations of the deal (e.g. commercial strategy, innovation, and contribution to market development.
• Company performance prior to transaction.
• How the sale or purchase impacted the broader industry(s) of the buyer and/or seller.

Technology Emerging

A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.

Sponsors: TBA

Criteria:

• Company must have been in operation before January 1, 2020. Revenues must be less than $50 million. If revenues are projected to exceed $50 million in 2023, please complete the Technology Company application.
• Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.

Key Considerations:

• Product or service innovation, including proprietary technology or other advantage.
• Company milestones including strategic decisions made by management that led to growth in revenues and/or earnings.
• Strength of management team including ability to raise capital.
• Demonstration of a sustainable and scalable business model.